GI ASC market not deterred by COVID-19, could hit $10.27B by 2027

The U.S. gastroenterology ASC market was worth $7.21 billion in 2019 and is expected to grow at a compound annual growth rate of 5.8 percent through 2027 to hit $10.27 billion, according to a Reports Globe report.

Advertisement
By: Staff

Leading companies in the market include:

  • Olympus
  • Johnson & Johnson
  • Medtronic
  • GE Healthcare
  • Boston Scientific
  • Cardinal Health

The majority of centers are either affiliated with a hospital, freestanding or physician-owned.

More articles on surgery centers:
3 ASC developments worth over $10M
7 critical steps for financial success in your ASC
10 most common procedures in ASCs

The real cost of nurse turnover is higher than most leaders realize

Recommended Whitepaper

Advertisement

Next Up in GI & Endoscopy

  • MUSC launches advanced endoscopy program

    The MUSC Shawn Jenkins Children’s Hospital in Charleston, S.C., has launched the MUSC Advanced Pediatric Endoscopy Program and Pancreas Center. …

    By: Cameron Cortigiano

  • Top 20 CPT codes for GI clinics, ASCs

    For GI clinics and ASCs, accurate coding and documentation are critical to protecting reimbursement, reducing denials and withstanding payer audits. …

    By: Patsy Newitt
Advertisement

Comments are closed.